SCHEMBL7753522

SCHEMBL7753522

CCCCCCCC/C=C/CCCCCCCC(=O)Nc1nc(CC(=O)O)cs1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.69
POLB P06746 2/20 0.56
SOAT2 O75908 1/20 0.53
SOAT1 P35610 1/20 0.53
GAA P10253 1/20 0.52
PDE1A P54750 1/20 0.52
PDE1B Q01064 1/20 0.52
PDE1C Q14123 1/20 0.52
PSMB11 A5LHX3 1/20 0.49
PSMA7 O14818 1/20 0.49
PSMB1 P20618 1/20 0.49
PSMA1 P25786 1/20 0.49
PSMA2 P25787 1/20 0.49
PSMA3 P25788 1/20 0.49
PSMA4 P25789 1/20 0.49
PSMB8 P28062 1/20 0.49
PSMB9 P28065 1/20 0.49
PSMA5 P28066 1/20 0.49
PSMB4 P28070 1/20 0.49
PSMB6 P28072 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971544 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7961319 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7971549 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7753510 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7757262 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7974926 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7961322 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7753534 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL7759510 1.00 PDE5A (0.69) PDE5APOLBSOAT2SOAT1GAA
SCHEMBL8926366 0.98 PDE5A (0.67) PDE5APOLBSOAT2SOAT1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281234-B1 TREATING METABOLIC DISORDERS MEDIATED BY INSULIN RESISTANCE OR HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION 2001-08-28 US claimed
EP-1077960-A1 (2-ACYLAMINOTHIAZOLE-4-YL)ACETIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP claimed
WO-1999058514-A1 (2-ACYLAMINOTHIAZOLE-4-YL)ACETIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO claimed
US-5688821-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS, SKIN DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1997-11-18 US claimed
US-6281234-B1 TREATING METABOLIC DISORDERS MEDIATED BY INSULIN RESISTANCE OR HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION 2001-08-28 US disclosed
EP-1077960-A1 (2-ACYLAMINOTHIAZOLE-4-YL)ACETIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP disclosed
WO-1999058514-A1 (2-ACYLAMINOTHIAZOLE-4-YL)ACETIC ACID DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO disclosed
US-5688821-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS, SKIN DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1997-11-18 US disclosed